⚠️ Suite à des publications sur le prélèvement d'organes d'un patient non décédé aux USA, la SFT rappelle dans cet article de @nicolasberrod pour @le_Parisien que le diagnostic de mort encéphalique est beaucoup plus sécurisé en France, où cette situation serait donc impossible !

donating a kidney is safer than it's ever been -- mortality from donor nephrectomy now one-third of what it was a decade ago, less than 1 in 10,000 -- spread the word! https://t.co/h7gIC9yazx

URGENT - Demande de remplacement pour le Centre Hospitalier d'Agen-Nérac

Highlighting the lack of evidence and the significant differences in usage across countries, this paper sheds light on our diverse practices. 🏥🔍  @NahidTabibzadeh https://t.co/ywkuWVJMqz

🔥 Nous recherchons un/une cadre de santé ds le Service Maladies Infectieuses et Tropicales @hopitalbichat @APHP Très bonne ambiance, activité variée et passionnante, ds un joli pavillon de @hopitalbichat N'hésitez pas à postuler / partager 🙏 👇 https://t.co/DpZooq3dlD

Efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients on chronic dialysis 🔓 https://t.co/QPqL7qtZCU

🚨 #JobAlert Assistant spécialiste aux Explorations Fonctionnelles Rénales @hopitalbichat dès novembre 2024 👉 DFG, exploration des troubles phosphocalciques, hydro-électrolytiques... 👉 HTA (IIR et résistante, centre d'Excellence Européen) 👉 Infos et contact: DM @EmmaVP5

💚Le 22 juin, c'était la Journée mondiale du don d'organes. Et jamais le don d’organes n’avait fait autant parler de lui. Médias, entreprises, grand public, associations, institutions et pro de santé : vous n'avez jamais été si nombreux à vous mobiliser ! 📢 En un mot : merci !

Mais @iledefrance , c’est aussi un taux d’opposition après décès de plus de 50%. Si on avait un taux proche de nos voisins espagnols par exemple (~15%) nous aurions ASSEZ d’organes chaque année pour greffer TOUS les nouveaux patients inscrits sur liste d’attente dans l’année.

Now at #ATC2024Philly : A prospective observational study including 2,882 kidney allograft recipients from 14 centers in Europe and the US shows that cell-free DNA can be used to detect kidney allograft rejection @AlexandreLoupy @olivieraubert

The SELECT trial on semaglutide for weight loss in obesity without diabetes! Weight loss was sustained over 4 years, semaglutide led to weight loss of -10.2%, reduced waist circumference by -7.7 cm, and improved waist-to-height ratio by -6.9%. #obesity #weightloss #semaglutide

The factor Xa inhibitor reversal agent andexanet reduced expansion of intracerebral hemorrhages caused by factor Xa inhibitors but resulted in more thrombotic events than usual care. Read the full ANNEXA-I trial results: https://t.co/2lut1AszcR

Presented at #HeartFailure2024: Among patients with symptomatic obstructive hypertrophic cardiomyopathy, treatment with aficamten led to a greater increase in peak oxygen consumption than placebo at 6 months. Full SEQUOIA-HCM phase 3 trial results: https://t.co/8M0wEtJ96d

Excited to share this research, supported by @com_SFNDT and @AgenceRecherche and published in @Arch_Pharm In patients on lithium treatment, polyuria levels correlate with dosage. But what about distal nephron remodeling and microcystic nephropathy? 1/2 https://t.co/ZAxXzuNjIk

Semaglutide—a new treatment for obesity-related heart failure with preserved ejection fraction? 1️⃣ Pooled analysis of the placebo-controlled STEP-HFpEF and STEP-HFpEF DM trials: https://t.co/X4COYs6TxM 2️⃣ Linked Comment: https://t.co/gBetzV0Eik

Among patients with obesity-related heart failure with preserved ejection fraction & type 2 diabetes, semaglutide produced greater reductions in symptoms, physical limitations & body weight than placebo at 1 year. Full STEP-HFpEF DM trial results: https://t.co/TbIZ7t391g #ACC24

Happy to share our paper just released in @KIReports showing that systematic screening for DSAs is useless in low risk immunological patients. However, it should be done if clinically indicated (sensitization event or impaired kidney function) @CHUdeToulouse

KDIGO is pleased to announce the publication of the 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD). Read the news release: https://t.co/BKJh9XvHjO Download the guideline: https://t.co/LQDNUeYPnz Read the guideline in Kidney

☀️Impact of Induction Therapy on the Risk of PTLD in Kidney Transplant Recipients with Donor-Recipient EBV Mismatch -American Journal of Transplantation @napatlee1 @wisit661 @AttiehRose @NephMao @ShennenMao ⁦@MayoClinicNeph⁩ 🙂🙏🏻 @amjtransplant

Original Article by Iske et al, "Transplanting old organs promotes senescence in young recipients" https://t.co/3Jm3pyCp5b